Review
doi: 10.1016/j.tibtech.2006.06.005.
Epub 2006 Jul 11.
Blood substitutes based on nanobiotechnology
Affiliations
- PMID: 16815577
- DOI: 10.1016/j.tibtech.2006.06.005
Item in Clipboard
Review
Blood substitutes based on nanobiotechnology
Trends Biotechnol.
2006 Aug.
Abstract
Stimulated by concerns of potential infective agents in donated blood, commercial enterprises have attempted to develop blood substitutes since the 1900s. After several years of development, a few of the many leads are showing promise. In this article, nanobiotechnological approaches that are now in phase III clinical trials are reviewed, followed by a discussion of how important basic knowledge gained is being used to develop new generations of blood substitutes based on nanobiotechnology.
Similar articles
-
Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.Artif Cells Blood Substit Immobil Biotechnol. 2006;34(6):551-66. doi: 10.1080/10731190600973808. Artif Cells Blood Substit Immobil Biotechnol. 2006. PMID: 17090428 Review.
-
The risks of blood transfusions and the shortage of supply leads to the quest for blood substitutes.AANA J. 2004 Oct;72(5):359-64. AANA J. 2004. PMID: 15529732 Review.
-
Perfluorinated blood substitutes and artificial oxygen carriers.Blood Rev. 1999 Sep;13(3):171-84. doi: 10.1054/blre.1999.0113. Blood Rev. 1999. PMID: 10527269 Review.
-
Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications.Expert Rev Med Devices. 2004 Sep;1(1):105-14. doi: 10.1586/17434440.1.1.105. Expert Rev Med Devices. 2004. PMID: 16293014 Review.
-
Nanobiotechnology: looking inside cell walls.Nat Nanotechnol. 2007 Mar;2(3):140-1. doi: 10.1038/nnano.2007.48. Nat Nanotechnol. 2007. PMID: 18654241 No abstract available.
Cited by
-
Bio-inspired nanomedicine strategies for artificial blood components.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Nov;9(6):10.1002/wnan.1464. doi: 10.1002/wnan.1464. Epub 2017 Mar 15. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017. PMID: 28296287 Free PMC article. Review.
-
Low modulus biomimetic microgel particles with high loading of hemoglobin.Biomacromolecules. 2012 Sep 10;13(9):2748-59. doi: 10.1021/bm3007242. Epub 2012 Aug 17. Biomacromolecules. 2012. PMID: 22852860 Free PMC article.
-
Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility.Clin Med Insights Blood Disord. 2016 Oct 27;9:33-41. doi: 10.4137/CMBD.S38461. eCollection 2016. Clin Med Insights Blood Disord. 2016. PMID: 27812292 Free PMC article. Review.
-
Hemoglobin-based Oxygen Carriers: Current State-of-the-art and Novel Molecules.Shock. 2019 Oct;52(1S Suppl 1):70-83. doi: 10.1097/SHK.0000000000001009. Shock. 2019. PMID: 31513123 Free PMC article. Review.
-
Development of a method to produce hemoglobin in a bioreactor culture of Escherichia coli BL21(DE3) transformed with a plasmid containing Plesiomonas shigelloides heme transport genes and modified human hemoglobin genes.Appl Environ Microbiol. 2011 Sep;77(18):6703-5. doi: 10.1128/AEM.05712-11. Epub 2011 Jul 29. Appl Environ Microbiol. 2011. PMID: 21803893 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
